Prelude Therapeutics Incorporated ( PRLD) - Stock Earnings
PRLD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -19.7 million USD | 6.5 million USD |
| 2025Q4 | -16.5 million USD | 5.6 million USD |
| 2026Q1 | -10.4 million USD | 4.6 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PRLD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -121.8 million USD | — USD |
| 2024 | -127.2 million USD | 7.0 million USD |
| 2025 | -99.5 million USD | 12.1 million USD |
| 2026 Est. | — | — |
PRLD
Price: $4.20
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65500
Market Capitalization: 216.9 million